
TransMedics fell 27.8% from $133.47 to $96.43, behind the S&P 500's +8.0%. Its worst day was May 6 (−23.2%), and its low came May 14 at $62.04.
Nov 19, 2025 – Nov 18, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.57 beat the $0.39 estimate on $160.8M revenue (est. $155.3M); FY revenue guidance of $727.0M–$757.0M against the $722.8M consensus.
−4.3% · S&P 500 +0.8%
Story events cover the past 12 months · Times ET
EPS of $0.30 missed the $0.61 estimate on $173.9M revenue (est. $174.4M); FY revenue guidance of $727.0M–$757.0M against the $739.2M consensus.
−23.2%, the year's worst day, on 8M shares, the year's heaviest volume · S&P 500 +1.4%
TransMedics closed at its lowest level of the year, 53.5% below where the year started.
−3.3% · S&P 500 +0.8%
TransMedics shares fell 12.0%, while the S&P 500 fell 0.7%.
−12.0% · S&P 500 −0.7%
EPS of $0.44 missed the $0.52 estimate on $189.9M revenue (est. $184.1M); FY revenue guidance of $737.0M–$757.0M against the $733.6M consensus.
−5.3% · S&P 500 −0.2%
EPS of $0.51 beat the $0.29 estimate on $203.0M revenue (est. $178.0M); FY revenue guidance of $750.0M–$760.0M against the $742.2M consensus.
+27.9%, the year's best day · S&P 500 +0.3%
Where it ended: a close of $96.43 on Nov 18, 2026. Up next: Q4 2026 earnings on Feb 23, 2027 (EPS est. $0.44, revenue est. $202.7M).
Nothing in the past 12 months.
All TMDX dividend historyReplay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for TMDX and SPY from Benzinga historical bars. Not investment advice.